Researchers use nanoparticles to target, treat inflammatory bowel diseases

Researchers are designing nanoparticles to treat inflammatory bowel diseases such as such as Chron’s disease and ulcerative colitis. Key innovations are the design of self-assembling nanoparticles that carry drugs and naturally target inflamed colons. The nanoparticles could deliver relief to more than 3 million Americans who suffer from the diseases.